Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04211584
Other study ID # TEN-001/18
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 18, 2017
Est. completion date October 28, 2022

Study information

Verified date November 2022
Source Center of Endosurgery and Lithotripsy, Moscow, Russia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

TENDERA is a multicenter randomized controlled trial to compare traditional entry point in the radial artery for TRI and distal puncture at the anatomical snuffbox area for transradial Interventions. The Investigators hypothesized that novel entry point in radial artery may lessen vascular access site complication rate and especially the radial artery late occlusion rate.


Description:

the forearm access will be made using traditional technique what was well described previously in the literature. The novel puncture site is located in the snuffbox area distal to the traditional radial access point. Thanks to surrounded anatomical conditions in anatomical snuffbox area vascular access site complications may be lessened comparing to forearm radial access site.


Recruitment information / eligibility

Status Completed
Enrollment 850
Est. completion date October 28, 2022
Est. primary completion date September 18, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 85 Years
Eligibility Inclusion Criteria: age 18-75 primary radial artery puncture radial artery diameter >1,5mm by ultrasound stable coronary disease less than 6F sheath needed patient height >185cm Exclusion Criteria: ACS AMI critically ill patients previous TRI procedure Raynaud's disease

Study Design


Related Conditions & MeSH terms


Intervention

Device:
transradial interventions
percutaneous coronary interventions in stable patients - diagnostic and treatment

Locations

Country Name City State
Russian Federation Center of Endosurgery Moscow

Sponsors (1)

Lead Sponsor Collaborator
Center of Endosurgery and Lithotripsy, Moscow, Russia

Country where clinical trial is conducted

Russian Federation, 

Outcome

Type Measure Description Time frame Safety issue
Primary Radial artery late occlusion loss of pulse or absent of artery lumen by ultrasound examonation 1 year
Secondary vascular access site related complications hematomas >5cm, bleeding, false aneurism, arterio-venous fistula 1 week, 3 months, 6 moths, 1 year